$MRT

Marti Technologies, Inc.: Marti Technologies Launches Ride-Hailing Service in 10 New Cities Across Türkiye

Marti Technologies (NYSE American: MRT) said it launched its ride-hailing service in 10 additional Turkish cities, expanding coverage to 30 cities and about 85% of Türkiye’s GDP. The company reported rider and driver shares outside Istanbul rose to 45% and 36% as of Aug. 11, 2026. Marti reiterated FY2026 guidance of $85M revenue and $7M Adjusted EBITDA, expecting accretion starting 2027.

Original reporting
Published Aug 12, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefTechnology
Primary signal
$MRT
Bullish
medium confidence
Mentioned
$MRT
Relevance
7/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$MRTBullishMed
01

Why it matters

The company expands ride-hailing availability from 20 to 30 cities, reaching about 85% of Türkiye’s GDP, and reiterates FY2026 guidance while stating the new launches should be accretive starting in 2027.

02

Market read

Traders may reassess the durability of Marti’s growth outside Istanbul and the credibility of its 2027 accretion path, even though FY2026 guidance is unchanged.

03

What to watch

The release does not quantify incremental revenue/EBITDA from the new cities, nor does it discuss regulatory, competitive, or incentive intensity that could affect margins.

Relevance 7/10Novelty 6/10Timing: today’s press release on ride-hailing expansion and reaffirmed FY2026 guidance

Background

Marti is a Turkey-focused mobility super app that entered ride-hailing in 2022 and is scaling from Istanbul to a nationwide footprint.

Company-level read

Ticker impact

$MRTBullishMedium confidence
Context

Marti (MRT) launched ride-hailing in 10 new Turkish cities, expanding coverage to 30 cities and about 85% of GDP.

Expected impact

Near-term reaction may be modest, but the 2027 accretion expectation and broader footprint could support a longer-duration valuation bid.

Evidence & confidence

This is a concrete operational expansion with quantified geographic reach and a stated financial implication (accretive starting 2027) while guidance is reaffirmed.

Market effects

Highlights competitive intensity and scaling dynamics in Turkey’s mobility super-app and ride-hailing market, potentially pressuring rivals’ unit economics as coverage expands.

Expanding beyond Istanbul to more cities may broaden demand capture across Turkey and improve driver supply utilization outside the main metro.

Limited direct global spillover, but it reinforces emerging-market platform scaling narratives for investors tracking mobility tech.

Counterpoint

City expansion may increase costs (driver onboarding, incentives, local operations) and the claimed accretion is deferred to 2027, so near-term profitability impact is uncertain.

Key entities

  • Marti Technologies, Inc.

    NYSE American-listed mobility super app expanding ride-hailing coverage across Türkiye.

  • Oguz Alper Oktem

    Founder and CEO cited on the growth pace outside Istanbul.

Related articles

$MRTHigh

Marti Technologies Shares Rise After Revenue Beat and Higher Guidance

Marti Technologies (MRT) reported Q2 2026 revenue of $20M, beating estimates and up 141% YoY. Despite a wider-than-expected adjusted loss of $0.15 per share, the company achieved positive adjusted EBITDA of $2.9M and raised its full-year outlook to $85M in revenue and $7M in adjusted EBITDA. Shares rose 5% in pre-market trading.

$MRTMedAI 8/10

Marti Technologies, Inc.: Marti Technologies Increases Fiscal Year 2026 Guidance on Accelerating Growth and Margin Expansion

Marti Technologies (NYSE American: MRT) raised its fiscal 2026 guidance, citing stronger-than-expected performance. The company now expects revenue of $85 million and adjusted EBITDA of $7 million, up from $70 million and $1 million previously. Management attributes the change to larger addressable markets, faster rider and driver adoption, and higher gross margins. It plans to report Q2 2026 results in August 2026.

$CRSPMedAI 8/10

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

CRISPR Therapeutics (CRSP) presented Phase 1a data for CTX310® at ESC Congress 2026, showing mean reductions of 79% in ANGPTL3, 48% in triglycerides, and 53% in LDL at the highest dose. The therapy was well tolerated with no serious adverse events. Data was also published in The New England Journal of Medicine. The company is advancing CTX310 in a Phase 1b trial and expects to provide an update in the second half of 2026.